| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |